Hong Kong SAR China · 
What does GT Healthcare Capital Partners invest in?
GT Healthcare Capital Partners invests most often at Series C and Series A (75% of the rounds on record), in sectors such as Longevity, Telehealth and Health.
GT Healthcare Capital Partners highlights
- 01
7 rounds on record
- 02
Mostly Series C and Series A: 75% of its rounds
- 03
Sole investor in 2 rounds, median $77M
What they do
GT Ventures has long focused on globally leading, revolutionary innovative drugs and medical technologies, driven by the organic combination of technological progress and market application as its investment impetus, committed to transforming the medical technology landscape in Asia and globally, and committed to starting from an investor's perspective to bring higher returns to patients worldwide.Translated from Chinese, from their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- LongevityTelehealthHealth
- Based in
- Hong Kong SAR China
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first7 appearances
- 2019
3 rounds
- Sept
- Jun
- Jan
- 2018
3 rounds
- Sept
- Jul
- Apr
- 2016
1 round
- Dec
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
2 of 6 we have independently watched raise
ExscientiaNanoporetechBeianOxfordinvestmentconsultantsOxfordsciencesinnovationTheranova
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.